IP Library Granted Patent US 6,872,705
Granted Patent B2
US 6,872,705 · App. 09/904,753 · Granted Mar 29, 2005

Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,872,705
App. No.
09/904,753
Granted
Mar 29, 2005
Kind
B2
Abstract

Methods for preserving ophthalmic compositions are disclosed. In one embodiment, such compositions include a liquid medium and an antimicrobial component which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide magainins, present in an amount effective as a preservative, are also disclosed. Preserved compositions useful for administering a therapeutic component to the eyes or caring for contact lenses are also included within the scope of the present invention.

Claims (23)

1. An ophthalmic composition comprising a carrier component, and a preservative component selected from the group consisting of magainin antimicrobial peptides, analogs of magainin antimicrobial peptides and mixtures thereof present in an amount effective as a preservative in said composition, wherein said composition is an oil-containing emulsion or an oil-containing suspension.

2. The composition of claim 1 wherein said preservative component is present in an effective amount less than about 10 milligrams per milliliter.

3. The composition of claim 1 which further comprises an effective amount of a buffer component to provide said composition with a desired pH.

4. The composition of claim 1 which further comprises an effective amount of a tonicity component to provide said composition with a desired osmolality.

5. The composition of claim 1 wherein said preservative component is a magainin antimicrobial peptide.

6. The composition of claim 1 wherein said preservative component is an analog of a magainin antimicrobial peptide comprising the amino acid sequence of SEQ ID NO: 4.

7. An ophthalmic composition comprising a carrier component, said composition further comprising an antimicrobial peptide mimetic present in an amount effective as a preservative in said composition, wherein said composition is an oil-containing emulsion or an oil-containing suspension.

8. The composition of claim 7 wherein said antimicrobial peptide mimetic is present in an effective amount less than about 10 milligrams per milliliter.

9. The composition of claim 7 which further comprises water and an effective amount of a buffer component to provide said composition with a desired pH.

10. The composition of claim 7 which further comprises an effective amount of a tonicity component to provide said composition with a desired osmolality.

11. The composition of claim 7 wherein said composition further includes a therapeutically effective component.

12. A method of preserving an ophthalmic composition comprising:

contacting an ophthalmic composition with a magainin analog with an amino acid sequence comprising of SEQ ID NO: 4 in an amount effective as a preservative in said composition, wherein said composition is an oil-containing emulsion or an oil-containing suspension.

13. An ophthalmic composition comprising a magainin antimicrobial analog with an amino acid sequence comprising of SEQ ID NO: 4 present in an amount effective as a preservative in said composition, wherein said composition is provided in a multidose format and wherein said composition is an oil-containing emulsion or an oil-containing suspension.

14. The composition of claim 1 , further comprising an effective amount of a therapeutically effective component.

15. The composition of claim 14 , wherein the therapeutically effective component comprises an antibiotic.

16. The composition of claim 15 , wherein the antibiotic is cyclosporin.

17. The composition of claim 14 , wherein the therapeutically effective component comprises a steroid.

18. The composition of claim 17 , wherein the steroid is prednisolone acetate.

19. The composition of claim 1 , wherein the preservative component is the sole preservative in said composition.

20. The composition of claim 1 , wherein the composition is a surgical irrigant.

21. The composition of claim 1 , further comprising a second antimicrobial component.

22. The composition of claim 21 , wherein the second antimicrobial component is a substantially non-oxidative antimicrobial component.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2003
From: ALLERGAN SALES, INC. (MERGED INTO ALLERGAN SALES, LLC 6/3/2002)
To: ALLERGAN, INC.
Reel/Frame 013898/0170 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2001
From: LYONS, ROBERT T.
To: ALLERGAN SALES, INC.
Reel/Frame 012010/0417 →